ArticleBMC women's health2025
Molecular prevalence of Chlamydia trachomatis infection among women attending gynaecological clinic for infertility evaluation.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Worldwide prevalence ofNew microbes and new infections · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChlamydia trachomatis is one of the most prevalent sexually transmitted bacterial infections and a significant cause of infertility in women. Despite its asymptomatic nature, the bacterium can ascend the reproductive tract, leading to pelvic inflammatory disease and tubal factor infertility.
objectiveThis study investigated the molecular prevalence of Chlamydia trachomatis infection (CTI) among women attending a gynaecological clinic for infertility evaluation.
methodsThis cross-sectional study involving 135 women was conducted at Edo University Teaching Hospital, Auchi, Nigeria. Endocervical swabs were collected during speculum examination and stored in DNA stabilization buffer at - 20 °C. Genomic DNA was extracted using the Qiagen DNA extraction kit, followed by PCR amplification targeting the ompA gene of C. trachomatis. Socio-demographic and clinical data were collected via structured questionnaires. Statistical significance was assessed using IBM SPSS Statistics version 25 (IBM Corp.) and the Chi-square test, with significance defined as p < 0.05.
resultsOut of 135 women screened, the molecular prevalence of CTI was 27.4%. The highest rate occurred among women of 18-26 years of age (31.6%), although age differences were not statistically significant (p = 0.38). Chlamydia trachomatis infection was significantly associated with a history of STIs (40.0% vs. 20.0%, p = 0.02) and PID (45.0% vs. 20.0%, p = 0.01). Women with secondary education had a higher prevalence (36.7%) than those with tertiary education (20.0%) (p = 0.05). No significant association was observed between vaginal symptoms and infection status, with malodorous discharge also failing to demonstrate statistical significance (p = 0.08). Logistic regression identified younger age (18-26 age group) (OR = 0.46, p = 0.007), STI history (OR = 0.24, p < 0.001), and PID (OR = 2.67, p = 0.005) as significant predictors of CTI. Tertiary education was protective (OR = 0.42, p = 0.028).
conclusionChlamydia trachomatis infection was prevalent among women attending a gynaecological clinic for infertility. Younger age, a history of STIs, and PID were significant predictors of infection, while tertiary education appeared protective. Targeted screening and educational interventions are essential to mitigate infection-related infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.